| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750) | PMV Pharmaceuticals, Inc | 2020-10-29 |
| The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy (NCT04591431) | Fondazione per la Medicina Personalizzata | 2020-10-07 |
| Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly (NCT03609177) | Dana-Farber Cancer Institute | 2020-04-15 |
| Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention (NCT03638453) | Dana-Farber Cancer Institute | 2019-05-28 |
| A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer (NCT03721926) | Massachusetts General Hospital | 2019-02-14 |
| Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors (NCT03967379) | Massachusetts General Hospital | 2019-02-01 |
| Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals (NCT03736746) | Dana-Farber Cancer Institute | 2018-11-16 |
| SHARE (Sharing Goals and Preferences) Study (NCT03392090) | Dana-Farber Cancer Institute | 2018-07-23 |
| Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation (NCT03244826) | Dana-Farber Cancer Institute | 2018-01-01 |
| Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients (NCT04340024) | National Cancer Centre, Singapore | 2015-09-30 |
| Circulating Tumor DNA Exposure in Peripheral Blood (NCT03517332) | Quantgene Inc. | 2015-01-01 |
| Development of an Intervention to Enhance Cancer Pain Management (NCT03752268) | Massachusetts General Hospital | 2014-04-15 |
| Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions (NCT03160274) | The University of Texas Health Science Center at San Antonio | 2005-10-19 |